A biotech company with nothing else to do might keep holding on to the dream - but a biotech company with other things to do would drop the idea at least for now. The preclinical rationale didnt work - move on ! Thats my view
I think it is necessary to get an assessment of data and mechanisms associated with the study of small cell lung cancer before Janssen will judge Dara out
in solid tumors.
But the rationale for dara i solid tumours was to kill suppressor cells and help the immune system back on track - and it did not work. The adverse events could be linked to NSCLC but we dont know
Bortset fra det...En eventuel artikel om at de små private investorer har paniksolgt i dag vil være en stor fejltagelse. Tværtimod er Nordnet og danske banker de største købere på faldet.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.